High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden.

MLA

Benayed, Ryma, et al. “High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 25, no. 15, Aug. 2019, pp. 4712–22. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-19-0225.

APA

Benayed, R., Offin, M., Mullaney, K., Sukhadia, P., Rios, K., Desmeules, P., Ptashkin, R., Won, H., Chang, J., Halpenny, D., Schram, A. M., Rudin, C. M., Hyman, D. M., Arcila, M. E., Berger, M. F., Zehir, A., Kris, M. G., Drilon, A., & Ladanyi, M. (2019). High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 25(15), 4712–4722. https://doi.org/10.1158/1078-0432.CCR-19-0225

Chicago

Benayed, Ryma, Michael Offin, Kerry Mullaney, Purvil Sukhadia, Kelly Rios, Patrice Desmeules, Ryan Ptashkin, et al. 2019. “High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 25 (15): 4712–22. doi:10.1158/1078-0432.CCR-19-0225.